click below
click below
Normal Size Small Size show me how
pharam
| Term | Definition |
|---|---|
| atropine | ACH receptor inhibitor |
| endrophonium | short term Ach esterase inhibitor |
| neostigmine | medium term Ach esterase inhibitor |
| physostigmine | medium term Ach esterase inhibitor |
| phyrimadostigmine | medium term Ach esterase inhibitor |
| isoflurophate | long term Ach esterase inhibitor |
| palidoxamine | reverse the inhibition of isoflurophate |
| Tacrine | Prototypical AChE inhibitor for AD |
| Donepezil | reversible acetylcholinesterase inhibitor |
| Rivastigmine | Parkinson disease |
| Galantamine | Competitive, reversible AChE inhibitor |
| succinylcholine | depolarizing agent |
| d-tubocuraine | non depolarizing agent main poision blocks the NMm RECEPTOR |
| curare | paralyzes affect the ach release, but it does not affect when they are taken in orally because the stomach breaks them down and releases it. |
| Fasiculation | muscle twitching |
| plasma acetylcholinesterase ;butyrylcholinesterase | to prolong the activity of break the Succinylcholine |
| suxamethonium or succylcholine | muscle relaxant during anaesthesia |
| sarin, tabun, soman | they are all gases used as nerve agents |
| Hemicholinium | Competitive inhibitor of choline uptake (not taken up itself |
| Vesamicol | Inhibition of packaging of acetylcholine into vesicles |
| Triethylcholine | Inhibits choline uptake, taken up and acetylated to acetyltriethylcholine. Stored as a false transmitter (i.e. normal vesicular release) |
| Muscarinic cholinomimetics | resemble the effects of parasympathetic stimulation |